Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women

Inclusion Criteria: * Having received ellaOne® as emergency contraception at the clinical site * Postmenarcheal adolescents or adult women * Willing to provide information on bleeding, sexual intercourses, method of contraception, concomitant medications and adverse events for the next two menstrual periods and to complete the diary accordingly * Willing to provide information on pregnancy outcome / delivery and newborn's health at delivery * Able to provide written informed consent * Willing to not participate in a clinical trial before the end of study participation Exclusion Criteria: * Currently participating in any interventional clinical trial (testing an Investigational Medicinal Product)